|
1.
|
A JemalR SiegelJ XuE WardCancer
statistics, 2010CA Cancer J Clin60277300201010.3322/caac.20073
|
|
2.
|
SA TomlinsDR RhodesS PernerRecurrent
fusion of TMPRSS2 and ETS transcription factor genes in prostate
cancerScience310644648200510.1126/science.111767916254181
|
|
3.
|
MA RubinCA MaherAM ChinnaiyanCommon gene
rearrangements in prostate cancerJ Clin
Oncol2936593668201110.1200/JCO.2011.35.191621859993
|
|
4.
|
C Kumar-SinhaSA TomlinsAM
ChinnaiyanRecurrent gene fusions in prostate cancerNat Rev
Cancer8497511200810.1038/nrc240218563191
|
|
5.
|
PC HollenhorstDA JonesBJ GravesExpression
profiles frame the promoter specificity dilemma of the ETS family
of transcription factorsNucleic Acids
Res3256935702200410.1093/nar/gkh90615498926
|
|
6.
|
T OikawaETS transcription factors:
possible targets for cancer therapyCancer
Sci95626633200410.1111/j.1349-7006.2004.tb03320.x15298723
|
|
7.
|
N HashiyaN JoM AokiIn vivo evidence of
angiogenesis induced by transcription factor Ets-1: Ets-1 is
located upstream of angiogenesis
cascadeCirculation10930353041200410.1161/01.CIR.0000130643.41587.DB15173033
|
|
8.
|
T RothhammerJC HahneA FlorinThe Ets-1
transcription factor is involved in the development and invasion of
malignant melanomaCell Mol Life
Sci61118128200410.1007/s00018-003-3337-814704859
|
|
9.
|
JC HahneAF OkuducuA KaminskiA FlorinF
SoncinN WernertEts-1 expression promotes epithelial cell
transformation by inducing migration, invasion and
anchorage-independent
growthOncogene2453845388200510.1038/sj.onc.120876115940256
|
|
10.
|
A SahinC VercamerA
KaminskiDominant-negative inhibition of Ets 1 suppresses tumor
growth, invasion and migration in rat C6 glioma cells and reveals
differentially expressed Ets 1 target genesInt J
Oncol343773892009
|
|
11.
|
Z ShaikhibrahimB LangerA LindstrotEts-1 is
implicated in the regulation of androgen co-regulator FHL2 and
reveals specificity for migration, but not invasion, of PC3
prostate cancer cellsOncol Rep2511251129201121258770
|
|
12.
|
Z ShaikhibrahimA LindstrotB LangerR
BuettnerN WernertComprehensive gene expression microarray analysis
of Ets-1 blockade in PC3 prostate cancer cells and correlations
with prostate cancer tissues: Insights into genes involved in the
metastatic cascadeInt J Mol Med278118192011
|
|
13.
|
Z ShaikhibrahimN WernertETS transcription
factors and prostate cancer: The role of the family prototype ETS-1
(Review)Int J Oncol4017481754201222366814
|
|
14.
|
J DittmerThe biology of the Ets1
proto-oncogeneMol Cancer229200310.1186/1476-4598-2-2912971829
|
|
15.
|
B WasylykSL HahnA GiovaneThe Ets family of
transcription factorsEur J
Biochem211718199310.1111/j.1432-1033.1993.tb19864.x8425553
|
|
16.
|
PC HollenhorstAA ShahC HopkinsBJ
GravesGenome-wide analyses reveal properties of redundant and
specific promoter occupancy within the ETS gene familyGenes
Dev2118821894200710.1101/gad.156170717652178
|
|
17.
|
G WeiR SrinivasanCZ Cantemir-StoneEts1 and
Ets2 are required for endothelial cell survival during embryonic
angiogenesisBlood11411231130200910.1182/blood-2009-03-21139119411629
|
|
18.
|
DK WatsonDP TurnerMN ScheiberVJ FindlayPM
WatsonETS transcription factor expression and conversion during
prostate and breast cancer progressionOpen Cancer
J32439201010.2174/1874079001003010024
|
|
19.
|
GH WeiG BadisMF BergerGenome-wide analysis
of ETS-family DNA-binding in vitro and in vivoEMBO
J2921472160201010.1038/emboj.2010.10620517297
|
|
20.
|
SA TomlinsA BjartellAM ChinnaiyanETS gene
fusions in prostate cancer: from discovery to daily clinical
practiceEur
Urol56275286200910.1016/j.eururo.2009.04.03619409690
|
|
21.
|
G PetrovicsA LiuS ShaheduzzamanFrequent
overexpression of ETS-related gene-1 (ERG1) in prostate cancer
transcriptomeOncogene2438473852200510.1038/sj.onc.120851815750627
|
|
22.
|
K RostadM MannelqvistOJ HalvorsenERG
upregulation and related ETS transcription factors in prostate
cancerInt J Oncol301932200717143509
|
|
23.
|
N CerveiraFR RibeiroA PeixotoTMPRSS2-ERG
gene fusion causing ERG overexpression precedes chromosome copy
number changes in prostate carcinomas and paired HGPIN
lesionsNeoplasia8826832200610.1593/neo.0642717032499
|
|
24.
|
C SunA DobiA MohamedTMPRSS2-ERG fusion, a
common genomic alteration in prostate cancer activates C-MYC and
abrogates prostate epithelial
differentiationOncogene2753485353200810.1038/onc.2008.18318542058
|
|
25.
|
G AlipovT NakayamaM ItoOverexpression of
Ets-1 proto-oncogene in latent and clinical prostatic
carcinomasHistopathology46202208200510.1111/j.1365-2559.2005.02059.x15693893
|
|
26.
|
JP BasuyauxE FerreiraD StehelinG
ButticeThe Ets transcription factors interact with each other and
with the c-Fos/c-Jun complex via distinct protein domains in a
DNA-dependent and -independent mannerJ Biol
Chem2722618826195199710.1074/jbc.272.42.261889334186
|
|
27.
|
MA SvenssonCJ LaFargueTY MacDonaldTesting
mutual exclusivity of ETS rearranged prostate cancerLab
Invest91404412201110.1038/labinvest.2010.17920975660
|
|
28.
|
Z ShaikhibrahimA LindstrotJ EllingerS
RogenhoferR BuettnerN WernertIdentification of immunity-related
genes in prostate cancer and potential role of the ETS family of
transcription factors in their regulationInt J Mol
Med28799807201121833467
|
|
29.
|
V EspinaJD WulfkuhleVS
CalvertLaser-capture microdissectionNat
Protoc1586603200610.1038/nprot.2006.85
|
|
30.
|
VJ SchebleM BraunR BeroukhimERG
rearrangement is specific to prostate cancer and does not occur in
any other common tumorMod
Pathol2310611067201010.1038/modpathol.2010.8720473283
|
|
31.
|
JP ClarkCS CooperETS gene fusions in
prostate cancerNat Rev
Urol6429439200910.1038/nrurol.2009.12719657377
|
|
32.
|
B HanR MehraK SulemanCharacterization of
ETS gene aberrations in select histologic variants of prostate
carcinomaMod
Pathol2211761185200910.1038/modpathol.2009.7919465903
|
|
33.
|
CC GuoJY DancerY WangTMPRSS2-ERG gene
fusion in small cell carcinoma of the prostateHum
Pathol421117201110.1016/j.humpath.2010.05.02621040948
|
|
34.
|
VJ SchebleM BraunT WilbertzERG
rearrangement in small cell prostatic and lung
cancerHistopathology56937943201010.1111/j.1365-2559.2010.03564.x20636794
|
|
35.
|
AM JoshuaA EvansT Van der KwastProstatic
preneoplasia and beyondBiochim Biophys
Acta1785156181200818166163
|
|
36.
|
M BraunVJ SchebleR MenonRelevance of
cohort design for studying the frequency of the ERG rearrangement
in prostate
cancerHistopathology5810281036201110.1111/j.1365-2559.2011.03862.x21707704
|
|
37.
|
VI SementchenkoCW SchweinfestTS PapasDK
WatsonETS2 function is required to maintain the transformed state
of human prostate cancer
cellsOncogene1728832888199810.1038/sj.onc.12022209879994
|
|
38.
|
GM CarboneS NapoliA ValentiniF CavalliDK
WatsonCV CatapanoTriplex DNA-mediated downregulation of Ets2
expression results in growth inhibition and apoptosis in human
prostate cancer cellsNucleic Acids
Res3243584367200410.1093/nar/gkh74415314206
|
|
39.
|
Z ShaikhibrahimM BraunP
NikolovRearrangement of the ETS genes ETV-1, ETV-4, ETV-5, and
ELK-4 is a clonal event during prostate cancer progressionHum
PatholMay72012(Epub ahead of print)
|
|
40.
|
PC HollenhorstL PaulMW FerrisBJ GravesThe
ETS gene ETV4 is required for anchorage-independent growth and a
cell proliferation gene expression program in PC3 prostate
cellsGenes Cancer110441052201110.1177/194760191039557821373373
|
